NEXXY yields 9.34% · JNJ yields 2.13%● Live data
📍 NEXXY pulled ahead of the other in Year 1
Combined, NEXXY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NEXXY + JNJ for your $10,000?
Nexi S.p.A. provides electronic money and payment services to banks, financial and insurance institutions, merchants, businesses, and public administration in Italy. The company offers acquiring services; configuration, activation, and maintenance of POS terminals; fraud prevention; and dispute management services, as well as customer support services. It also provides a range of issuing services, such as issue, supply, and management of private and corporate payment cards; installation and management of ATM's; clearing services; and digital banking services for the management of current accounts and payments. In addition, the company offers software applications for invoice management and storage, prepaid card reloading, bill payments, and postal payments. Nexi S.p.A. has a strategic agreement with Intesa Sanpaolo S.p.A. to acquire the PBZ Card's merchant business in the Croatian market. The company was founded in 1939 and is based in Milan, Italy.
Full NEXXY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.